Sharon Larkin
Director/Board Member at SENSEONICS HOLDINGS, INC.
Net worth: 125 119 $ as of 30/04/2024
Profile
Sharon D.
Larkin is currently the Director at Senseonics, Inc. and an Independent Director at Senseonics Holdings, Inc. Previously, she worked at Abbott Laboratories as the Divisional VP-HR & Medical Devices Group from 2011 to 2015.
She also served as the Senior VP-Human Resources & Administration at Assertio Therapeutics, Inc. from 2017 to 2020.
Ms. Larkin completed her undergraduate degree at Georgia Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 299,327 ( 0.06% ) | 125 119 $ | 30/04/2024 |
Sharon Larkin active positions
| Companies | Position | Start |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | Director/Board Member | 08/12/2021 |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Director/Board Member | 01/12/2021 |
Former positions of Sharon Larkin
| Companies | Position | End |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Administrative Officer | 01/01/2020 |
| ABBOTT LABORATORIES | Human Resources Officer | 01/09/2015 |
Training of Sharon Larkin
| Georgia Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Private companies | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Technology |
- Stock Market
- Insiders
- Sharon Larkin
